Zum Hauptinhalt springen

Risk of bleeding amongst warfarin and direct oral anticoagulant users prescribed immediate antibiotics for respiratory tract infection: Cohort study.

Ahmed, H ; Reeve, N ; et al.
In: Pharmacoepidemiology and drug safety, Jg. 33 (2024-05-01), Heft 5, S. e5794
Online academicJournal

Titel:
Risk of bleeding amongst warfarin and direct oral anticoagulant users prescribed immediate antibiotics for respiratory tract infection: Cohort study.
Autor/in / Beteiligte Person: Ahmed, H ; Reeve, N ; Farewell, D ; Hamilton, F ; Ponsford, M ; Hippisley-Cox, J ; Noble, S
Link:
Zeitschrift: Pharmacoepidemiology and drug safety, Jg. 33 (2024-05-01), Heft 5, S. e5794
Veröffentlichung: Chichester, West Sussex : Wiley, 1992-, 2024
Medientyp: academicJournal
ISSN: 1099-1557 (electronic)
DOI: 10.1002/pds.5794
Schlagwort:
  • Humans
  • Female
  • Male
  • Retrospective Studies
  • Aged
  • Middle Aged
  • Aged, 80 and over
  • Cohort Studies
  • England epidemiology
  • Incidence
  • Administration, Oral
  • Warfarin adverse effects
  • Warfarin administration & dosage
  • Respiratory Tract Infections drug therapy
  • Respiratory Tract Infections epidemiology
  • Anti-Bacterial Agents adverse effects
  • Anti-Bacterial Agents administration & dosage
  • Anti-Bacterial Agents therapeutic use
  • Anticoagulants adverse effects
  • Anticoagulants administration & dosage
  • Hemorrhage chemically induced
  • Hemorrhage epidemiology
Sonstiges:
  • Nachgewiesen in: MEDLINE
  • Sprachen: English
  • Publication Type: Journal Article; Research Support, Non-U.S. Gov't
  • Language: English
  • [Pharmacoepidemiol Drug Saf] 2024 May; Vol. 33 (5), pp. e5794.
  • MeSH Terms: Warfarin* / adverse effects ; Warfarin* / administration & dosage ; Respiratory Tract Infections* / drug therapy ; Respiratory Tract Infections* / epidemiology ; Anti-Bacterial Agents* / adverse effects ; Anti-Bacterial Agents* / administration & dosage ; Anti-Bacterial Agents* / therapeutic use ; Anticoagulants* / adverse effects ; Anticoagulants* / administration & dosage ; Hemorrhage* / chemically induced ; Hemorrhage* / epidemiology ; Humans ; Female ; Male ; Retrospective Studies ; Aged ; Middle Aged ; Aged, 80 and over ; Cohort Studies ; England / epidemiology ; Incidence ; Administration, Oral
  • References: Anticoagulants, including non‐vitamin K antagonist oral anticoagulants (NOACs). Guidance and guidelines. National Institute of Health and Care Excellence (NICE); 2018. ; Ahmed H, Whitaker H, Farewell D, Hippisley‐Cox J, Noble S. Respiratory tract infection and risk of bleeding in oral anticoagulant users: self‐controlled case series. BMJ. 2021;375:e068037. ; Scarlatescu E, Tomescu D, Arama SS. Sepsis‐associated coagulopathy. J Crit Care Med. 2016;2:156‐163. ; Zhang Q, Bal‐dit‐Sollier C, Drouet L, et al. Interaction between acetaminophen and warfarin in adults receiving long‐term oral anticoagulants: a randomized controlled trial. Eur J Clin Pharmacol. 2011;67:309‐314. ; Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE. Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA. 1998;279:657‐662. ; Richards RK. Influence of fever upon the action of 3,3’‐methylene‐bis‐(4‐hydroxycoumarin) (dicumarol). Science. 1943;97:313. ; Warfarin 0.5mg Tablets – Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/3064/smpc#gref. ; Warfarin. Interactions. BNF content published by NICE. https://bnf.nice.org.uk/interactions/warfarin/. ; Walther B, Philip Karl J, Booth SL, Boyaval P. Menaquinones, bacteria, and the food supply: the relevance of dairy and fermented food products to vitamin K requirements. Adv Nutr. 2013;4:463‐473. ; Juurlink DN. Drug interactions with warfarin: what clinicians need to know. CMAJ. 2007;177:369‐371. ; Garonzik S, Byon W, Myers E, Xiodong L, Marchisin D, Murthy B. The effects of clarithromycin on the pharmacokinetics of Apixaban in healthy volunteers: a single‐sequence crossover study. Am J Cardiovasc Drugs. 2019;19:561‐567. ; Delavenne X, Ollier E, Basset T, et al. A semi‐mechanistic absorption model to evaluate drug‐drug interaction with dabigatran: application with clarithromycin. Br J Clin Pharmacol. 2012;76(1):107‐113. ; Mueck W, Kubitza D, Becka M. Co‐administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects. Br J Clin Pharmacol. 2013;76(3):455‐466. ; Baillargeon J, Holmes HM, Lin YL, Raji MA, Sharma G, Kuo YF. Concurrent use of warfarin and antibiotics and the risk of bleeding in older adults. Am J Med. 2012;125:183‐189. ; Lane MA, Zeringue A, McDonald JR. Serious bleeding events due to warfarin and antibiotic co‐prescription in a cohort of veterans. Am J Med. 2014;127:657‐663.e2. ; Fischer HD, Juurlink DN, Mamdani MM, Kopp A, Laupacis A. Hemorrhage during warfarin therapy associated with Cotrimoxazole and other urinary tract anti‐infective agents: a population‐based study. Arch Intern Med. 2010;170:617‐621. ; Hill K, Sucha E, Rhodes E, et al. Risk of hospitalization with hemorrhage among older adults taking clarithromycin vs azithromycin and direct oral anticoagulants. JAMA Intern Med. 2020;180:1052‐1060. ; Clark NP, Delate T, Riggs CS, et al. Warfarin interactions with antibiotics in the ambulatory care setting. JAMA Intern Med. 2014;174:409‐416. ; Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol. 2015;44:827‐836. ; Primary care data for public health research. CPRD. https://cprd.com/primary-care-data-public-health-research. ; Campbell J, Dedman D, Eaton SC, Gallagher A, Williams T. Is the CPRD GOLD population comparable to the U.K. population? Pharmacoepidemiol Drug Saf. 2013;22:280. ; Padmanabhan S, Carty L, Cameron E, Ghosh RE, Williams R, Strongman H. Approach to record linkage of primary care data from Clinical Practice Research Datalink to other health‐related patient data: overview and implications. Eur J Epidemiol. 2019;34:91‐99. ; Millett ERC, Quint JK, Smeeth L, Daniel RM, Thomas SL. Incidence of community‐acquired lower respiratory tract infections and pneumonia among older adults in the United Kingdom: a population‐based study. PLoS One. 2013;8:e75131. ; Mcdonald L, Sammon CJ, Samnaliev M, Ramagopalan S. Under‐recording of hospital bleeding events in UK primary care: a linked clinical practice research datalink and hospital episode statistics study. Clin Epidemiol. 2018;4(10):1155‐1168. ; Yoshida K, Solomon DH, Kim SC. Active‐comparator design and new‐user design in observational studies. Nat Rev Rheumatol. 2015;11:437‐441. ; Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients. J Thromb Haemost. 2005;3:692‐694. ; Gallagher AM, van Staa TP, Murray‐Thomas T, et al. Population‐based cohort study of warfarin‐treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomes. BMJ Open. 2014;4:e003839. ; Vinogradova Y, Coupland C, Hill T, Hippisley‐Cox J. Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care. BMJ. 2018;362:k2505. ; Kaatz S, Ahmad D, Spyropoulos AC, Schulman S. Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH. J Thromb Haemost. 2015;13:2119‐2126. ; Package “mice”: Multivariate Imputation by Chained Equations. 2022 https://cran.r-project.org/web/packages/mice/index.html. ; Graham JW, Olchowski AE, Gilreath TD. How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prev Sci Prev Sci. 2007;8:206‐213. ; von Hippel PT. How many imputations do you need? A two‐stage calculation using a quadratic rule. Sociol Methods Res. 2018;49:699‐718. ; Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med. 2007;26:734‐753. ; Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samples. Stat Med. 2009;28:3083‐3107. ; Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515‐526. ; Rubin DB. Multiple Imputation for Nonresponse in Surveys. John Wiley & Sons, Inc.; 1987. ; Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34:3661‐3679. ; Musher DM, Abers MS, Corrales‐Medina VF. Acute infection and myocardial infarction. N Engl J Med. 2019;380:171‐176. ; Jansen AJG, Spaan T, Low HZ, et al. Influenza‐induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity. Blood Adv. 2020;4:2967‐2978. ; Yeaman MR. Platelets in defense against bacterial pathogens. Cell Mol Life Sci. 2010;67(4):525‐544. ; Acute upper gastrointestinal bleeding in over 16s: Guidance and guidelines. National Institute of Health and Care Excellence (NICE). 2012. ; Chavez‐Tapia NC, Barrientos‐Gutierrez T, Tellez‐Avila F, et al. Meta‐analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding – An updated Cochrane review. Aliment Pharmacol Ther. 2011;34:509‐518. ; Thalhieimer U, Triantes CK, Samonakis DN, Patch D, Burroughs AK. Infection, coagulation, and variceal bleeding in cirrhosis. Gut. 2005;54:556‐563.
  • Grant Information: Health and Care Research Wales (NIHR-FS(A)-2020)
  • Contributed Indexing: Keywords: antibiotic; anticoagulant; cohort studies; haemorrhage; infection
  • Substance Nomenclature: 5Q7ZVV76EI (Warfarin) ; 0 (Anti-Bacterial Agents) ; 0 (Anticoagulants)
  • Entry Date(s): Date Created: 20240429 Date Completed: 20240429 Latest Revision: 20240429
  • Update Code: 20240429

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -